| 2022-11-21 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 22,500 0.0197% | $220.00 | $4.95M | -5.17% | |
| 2018-03-13 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 34,234 0.0356% | $150.00 | $5.14M | -35.36% | |
| 2017-11-02 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 40,000 0.0249% | $80.05 | $3.2M | -21.87% | |
| 2015-04-21 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 16,330 0.0209% | $130.02 | $2.12M | -18.97% | |
| 2015-03-19 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 10,000 0.0122% | $120.00 | $1.2M | -13.41% | |
| 2015-03-05 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 1,412 0.0014% | $89.43 | $126,275 | -6.35% | |
| 2014-12-08 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.031% | $81.70 | $2.45M | -1.11% | |
| 2014-11-11 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 10,000 0.0089% | $65.05 | $650,450 | +6.35% | |
| 2014-10-22 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 10,000 0.0091% | $60.05 | $600,450 | +17.64% |